Liver abnormalities in pulmonary arterial hypertension

Nils P. Nickel, Gian M. Galura, Marc J. Zuckerman, M. Nawar Hakim, Haider Alkhateeb, Debabrata Mukherjee, Eric D. Austin, Gustavo D. Heresi

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Pulmonary arterial hypertension (PAH) is a cardiopulmonary disease with high mortality. In recent years, it has been recognized that PAH is a multi-organ system disease, involving the systemic circulation, kidneys, skeletal muscles, and the central nervous system, among others. Right heart failure produces congestive hepatopathy, a disease state that has direct consequences on liver biochemistry, histology, and systemic glucose and lipid metabolism. This article aims to summarize the consequences of congestive hepatopathy with an emphasis on liver biochemistry, histology, and PAH-targeted therapy. Furthermore, PAH-specific changes in glucose and lipid metabolism will be discussed.

Original languageEnglish (US)
JournalPulmonary Circulation
Issue number4
StatePublished - 2021
Externally publishedYes


  • lipid metabolism
  • liver
  • pulmonary arterial hypertension
  • venous congestion

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Liver abnormalities in pulmonary arterial hypertension'. Together they form a unique fingerprint.

Cite this